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We investigated the effect of South American coral snake (Micrurus lemniscatus lemniscatus) 
venom on neurotransmission in vertebrate nerve-muscle preparations in vitro. The venom 
showed calcium-dependent PLA2 activity and caused irreversible neuromuscular blockade 
(0.1-30 µg/ml) in chick biventer cervicis (BC) and mouse phrenic nerve-diaphragm (PND) 
preparations. In BC preparations, contractures to exogenous acetylcholine and carbachol 
(CCh), but not KCl, were abolished by venom concentrations ≥0.3 µg/ml; in PND 
preparations, the amplitude of the tetanic response was progressively attenuated, but with 
little tetanic fade. In low Ca2+ physiological solution, venom (10 µg/ml) caused 
neuromuscular blockade in PND preparations within ~10 min that was reversible by washing; 
the addition of Ca2+ immediately after the blockade temporarily restored the twitch responses, 
but did not prevent the progression to irreversible blockade. Venom (10 µg/ml) did not 
depolarize diaphragm muscle, prevent depolarization by CCh, or cause muscle contracture or 
histological damage. Venom (3 µg/ml) had a biphasic effect on the frequency of miniature 
end-plate potentials, but did not affect their amplitude; there was a progressive decrease in the 
amplitude of evoked end-plate potentials. The amplitude of compound action potentials in 
mouse sciatic nerve was unaffected by venom (10 µg/ml). Pre-incubation of venom with coral 
snake antivenom (Instituto Butantan) at the recommended antivenom:venom ratio did not 
neutralize the neuromuscular blockade in PND preparations, but total neutralization was 
achieved with a 10-fold greater volume of antivenom. The addition of antivenom after 50% 
and 80% blockade restored the twitch responses.  These results show that M. l. lemniscatus 
venom causes potent, irreversible neuromuscular blockade, without myonecrosis. This 
blockade is apparently mediated by pre- and postsynaptic neurotoxins and can be reversed by 
coralsnake antivenom.  
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Coral snakes of the genus Micrurus are the major representatives of the family 
Elapidae in the Americas and are widely distributed from the southeastern United States to 
central-southern Argentina (Roze, 1996; Silva Jr. et al., 2016a). Despite the large diversity of 
Micrurus in Brazil (~34 spp.) (Silva Jr. et al., 2016b), bites by this genus account for ≤1% of 
venomous snakebites reported annually in this country (Bucaretchi et al., 2016a,b). This low 
incidence of bites probably reflects the low population density of these snakes, their 
unaggressive behavior and the difficulty in inoculating venom because of their small mouth 
and short fangs. 
Systemic envenomation by coral snakes is characterized by peripheral neurotoxicity 
that is mediated by two major groups of toxins: (1) -neurotoxins that block postsynaptic 
nicotinic (cholinergic) receptors and are part of the three-finger toxin (3FTx) family, and (2) 
-neurotoxins that are phospholipases A2 (PLA2) and cause potent presynaptic blockade 
(Gutiérrez et al., 2016; Lomonte et al., 2016; Aird et al., 2017). Clinically, neurotoxicity is the 
most important activity of coral snake venoms because of the risk of respiratory failure and 
death as a consequence of peripheral neuromuscular blockade (Warrell, 2004; Bucaretchi et 
al., 2016a,b; Risk et al., 2016). 
Despite the large number of Micrurus in Brazil, only a few of them (M. altirostris, M. 
averyi, M. corallinus, M. decoratus, M. filiformis, M. frontalis, M. hemprichii, M. ibiboboca, 
M. lemniscatus, M. spixii and M. surinamensis) have been conclusively implicated in human 
envenomation (Bucaretchi et al., 2016a,b; Melgarejo et al., 2016; Risk et al., 2016; Rodrigo et 
al., 2016; Souza et al., 2016; da Silva et al., 2018; Strauch et al., 2018), with M. lemniscatus 
being the third most frequent species involved (Bucaretchi et al., 2016b).  Currently Micrurus 
lemniscatus is a species composed of three subspecies (M. l. carvalhoi, M. l. helleri and M. l. 
lemniscatus). Figure 1 shows the geographic distribution of these three subspecies in Brazil 
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and neighbouring countries: (1) M. l. carvalhoi is distributed along the Brazilian east coast 
from the northeast to southeast of the country and in parts of central, central-western, 
southeastern and southern Brazil, as well as eastern Paraguay and northeastern Argentina, (2) 
M. l. helleri  occurs in the western Brazilian Amazon and in Colombia, Ecuador, Peru and 
Bolivia east of the Andes, and (3) M. l. lemniscatus is found in the central Brazilian Amazon, 
northern Brazil (states of Amapá, Maranhão e Pará) and in Guyana, Suriname and French 
Guiana.  
The precise taxonomic relationship among these three subspecies is unclear, with M. l. 
helleri probably being synonymous with M. l. lemniscatus, and M. l. carvalhoi possibly being 
a separate species (Silva Jr. et al., 2016b).  As shown in Fig. 1, there is considerable overlap 
in the geographic distributions of M. diutius and M. l. lemniscatus, and the distribution of M. 
l. lemniscatus may well include the indicated range of M. l. helleri, although the true extent of 
overlap between the latter two subspecies is unclear (Roze, 1996; Campbell and Lamar, 2004; 
Silva Jr. et al., 2016b). There is also uncertainty regarding the eastern limits of M. l. 
lemniscatus and western limits of M. l. carvalhoi and the potential areas of overlap between 
these two subspecies throughout most of their ranges, primarily because of the low number of 
specimens for these subspecies in herpetological collections of these regions. Human 
envenomation by these three subspecies has been reported, e.g., M. l. carvalhoi (Rosenfeld, 
1971; Ribeiro and Jorge, 1986; Nishioka et al., 1993; Bucaretchi et al., 2006; Risk et al., 
2016), M. l. helleri (Warrell, 2004; Manock et al., 2008) and M. l. lemniscatus (Brazil and 
Brazil Filho, 1933).  
Appreciation of the taxonomic status of this species is important in order to avoid 
confusion in the toxinological literature relating to the subspecies currently included in this 
species.  Thus, although various studies have reported the characterization of venom (Brazil 
and Brazil Filho, 1933; Vital Brazil, 1965; Cecchini et al., 2005; Ciscotto et al., 2011; Santos 
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et al., 2012; Tanaka et al., 2010, 2016; Ramos et al., 2017) and toxins (Oliveira et al., 2008; 
Silva et al., 2011; Carvalho et al., 2014; Casais-e-Silva et al., 2016) from ‘M. lemniscatus’, 
examination of the source of the venoms used (geographic origin and/or supplier) indicates 
that these studies relate to M. l. carvalhoi and not to M. l. lemniscatus or M. l. helleri. 
Therefore, these reports cannot be considered to be representative of the species M. 
lemniscatus. As with other Micrurus venoms, proteomic analyses have shown that 3FTx and 
PLA2 are the main constituents of M. l. carvalhoi and M. l. lemniscatus venoms (Ciscotto et 
al., 2011; Aird et al., 2017), although there is considerable variation in the proportion of these 
toxin groups in each venom: 2.3% 3FTx and 48.6% PLA2 for M. l. carvalhoi from the state of 
Goiás, compared to 59% 3FTx and 9% PLA2 for this subspecies from ‘southeastern Brazil’ 
(probably the state of Minas Gerais), and 34.3% 3FTx and 19.4% PLA2 for M. l. lemniscatus 
from Altamira, in the state of Pará.   
Whereas the peripheral (Brazil and Brazil Filho, 1933; Vital Brazil, 1965; Cecchini et 
al., 2005) and central (Oliveira et al., 2008; Carvalho et al., 2014) neurotoxicity of M. l. 
carvalhoi venom has been studied, nothing is known of the neurotoxicity of other M. 
lemniscatus subspecies (M. l. lemniscatus and M. l. helleri), although a clinical report 
suggests that neuromuscular blockade by the latter subspecies may be insensitive to reversal 
by neostigmine (Manock et al., 2008), a potentially useful ancillary measure for treating 
envenomation by coral snake venoms with a predominantly postsynaptic site of action 
(Coelho et al., 1992; Vital Brazil and Vieira, 1996; Bucaretchi et al., 2016b).  In this work, we 
undertook a detailed investigation of the neurotoxicity of M. l. lemniscatus venom on 
neurotransmission in vertebrate (avian and mammalian) nerve-muscle preparations in vitro 
using a combination of myographic and electrophysiological approaches to determine the 
principal sites of action. We also examined the ability of coral snake antivenom produced by 
the Instituto Butantan (São Paulo, SP, Brazil) to neutralize the neurotoxicity of this venom in 
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vitro. The findings reported here will be of interest to those investigating the pharmacology of 
Micrurus venoms and to clinicians who may have to treat envenomation by M. l. lemniscatus 
with antivenom produced by the Instituto Butantan.  
 
Materials and methods 
Reagents and venom  
Acetylcholine chloride, carbachol, p-bromophenacyl bromide, neutral red, 4-nitro-3-
octanoyloxy-benzoic acid and tetrodotoxin (TTX) were obtained from Sigma-Aldrich 
Chemical Co. (St. Louis, MO, USA) and d-tubocurarine chloride was from Abbott 
Laboratórios do Brasil Ltda. (São Paulo, SP, Brazil). All salts for the physiological solutions 
were of analytical grade. Micrurus l. lemniscatus venom was obtained from twelve adult 
snakes (7 males; 5 females) from Altamira in the northern Brazilian state of Pará in the 
Brazilian Amazon (3°25'55"S and 51°56'6"W); the snakes were identified by one of the co-
authors (NJS), a professional herpetologist with extensive experience in coral snake 
taxonomy. The venom was lyophilized and stored at -20 °C until used.  
 
Animals 
Male BALB/c mice (25-30 g; 2-3 months old) obtained from the Multidisciplinary 
Center for Biological Investigation (CEMIB/UNICAMP) were housed in plastic cages (5-
10/cage) with a wood-shaving substrate, at 23 ± 1 °C in ventilated stands (Alesco®) on a 12 h 
light/dark cycle with lights on at 6 a.m. Male HY-line chicks (4-8 days old) were provided by 
Globo Aves Agricola Ltda. (Campinas, SP, Brazil) and housed in metal cages with a sawdust 
substrate at 23-25 °C. The rodents and chicks had free access to food and water. When 
required, the animals were killed with isoflurane immediately prior to the experiments. The 
animal experiments were approved by an institutional Committee for Ethics in Animal Use 
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(CEUA/UNICAMP, protocol no. 3477-1) and were done according to the general ethical 
guidelines for animal use established by the Brazilian Society of Laboratory Animal Science 
(SBCAL) and Brazilian legislation (Federal Law no. 11,794, of October 8, 2008), in 
conjunction with the guidelines for animal experiments established by the Brazilian National 
Council for Animal Experimentation (CONCEA) and EU Directive 2010/63/EU for the 
Protection of Animals Used for Scientific Purposes.  
 
PLA2 activity and inhibition by p-bromophenacyl bromide (p-BPB) 
PLA2 activity was assayed essentially as described by Carregari et al. (2013). The 
standard assay mixture contained 200 l of buffer (10 mM Tris-HCl, 10 mM CaCl2 and 100 
mM NaCl, pH 8.0), 20 l of substrate (3 mM 4-nitro-3-octanoyloxy-benzoic acid) and 20 l 
of venom (0.1 mg/ml dissolved in saline) in a final volume of 240 l. Some assays were done 
in low Ca2+ (0.36 mM) buffer solution. After adding venom, the mixture was incubated for 30 
min at 37 °C or room temperature. Enzymatic activity was expressed as the initial velocity of 
reaction and was calculated based on the increase in absorbance (425 nm) after 20 min. All 
assays were done in triplicate with readings at 30 s intervals using a SpectraMax 340 
multiwell plate reader (Molecular Devices). PLA2 activity was inhibited by incubating venom 
with p-BPB essentially as described elsewhere (Díaz-Oreiro and Gutiérrez, 1997); aliquots of 
these p-BPB incubated mixtures were then tested for biological activity. 
 
Twitch-tension experiments 
Chick biventer cervicis (BC) preparations 
Chick biventer cervicis (BC) nerve-muscle preparations were mounted under a resting 
tension of 1 g in 5 ml organ baths (Panlab, Barcelona, Spain) containing aerated (5% CO2 and 
95% O2) Krebs solution (composition, in mM: NaCl 119, KCl 4.7, CaCl2 1.9, KH2PO4 1.2, 
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MgSO4 1.2, NaHCO3 25 and glucose 11.7, pH 7.5) at 37 °C and allowed to stabilize for 10 
min prior to use, as described elsewhere (Floriano et al., 2013; Fernandes et al., 2014). Field 
stimulation (0.1 Hz, 0.2 ms) was delivered from an LE 12406 TC stimulator (Panlab) and the 
muscle twitches were recorded using a TRI201AD force displacement transducer coupled to a 
Quad Bridge Amp and LabChart 6.0 software (all from ADInstruments, Bella Vista, 
Australia). Muscle responses to exogenous acetylcholine (ACh, 1 mM), carbachol (CCh, 20 
M) and KCl (40 mM) were obtained before and after incubation with venom (0.1-30 μg/ml) 
to screen for postsynaptic neurotoxicity and myotoxicity (Harvey et al., 1994). 
 
Mouse phrenic nerve-diaphragm (PND) preparations 
Mouse phrenic nerve-diaphragm (PND) preparations were mounted under a resting 
tension of 1 g in 5 ml organ baths containing aerated (5% CO2 and 95% O2) Tyrode solution 
(composition, in mM: NaCl 137, KCl 2.7, CaCl2 1.8, MgCl2 0.49, NaH2PO4 0.42, NaHCO3 
11.9 and glucose 11.1, pH 7.0) at 37 °C and allowed to stabilize for 10 min prior to use, as 
described elsewhere (Floriano et al., 2013; Herrera et al., 2016). Supramaximal stimuli (0.1 
Hz, 0.2 ms) were delivered to the nerve from a Grass S88 stimulator (Grass Instrument Co., 
Quincy, MA, USA) and the muscle twitches were recorded using the same system as 
described above. After stabilization, the preparations were incubated with venom (0.1-30 
μg/ml) for 60 min or until complete neuromuscular blockade. In some experiments, PND 
preparations were maintained in physiological salt solution containing low Ca2+ (0.36 mM) 
for at least 15 min to ensure that the twitch amplitude was stable prior to the addition of 
venom (10 g/ml).  To ensure that direct stimulation of the nerve-muscle preparations did not 
contribute to the overall tension recorded, MgCl2 (40 mM) was added to the bath and in all 
cases the indirectly evoked twitches were completely blocked. The MgCl2 was subsequently 
removed by successive washes until the twitch amplitude had returned to control level.  
9 
 
The reversibility of the neuromuscular blockade in normal and low Ca2+ solution was 
assessed by adding neostigmine (29 M, an acetylcholinesterase inhibitor) or 3,4-
diaminopyridine (3,4-DAP, a potassium channel blocker) to the preparations after >90% 
blockade and assessing the recovery of twitch tension. In the low Ca2+ protocols, after 
incubation with NEO or 3,4-DAP Ca2+ was added to the organ bath to restore the 
concentration to normal (1.8 mM Ca2+) and the effect of this restoration on muscle twitch 
tension was assessed. To examine the effects of venom (10 g/ml) on direct muscle 
stimulation, some preparations in normal Ca2+ solution were incubated with d-tubocurarine 
(d-Tc, 14.7 M); direct muscle stimulation was achieved with supramaximal pulses (0.1 Hz, 2 
ms). Some preparations were indirectly stimulated with high frequency stimuli (70 Hz, 0.2 
ms, ~4V) to produce tetanic responses; the preparations were stimulated at 10 min intervals, 
with tetanic responses being recorded for 10 s. 
  
Neutralization of neurotoxicity by coral snake antivenom 
The ability of coral snake antivenom produced by the Instituto Butantan (São Paulo, 
SP, Brazil) to neutralize the venom-induced neuromuscular blockade in mouse PND was 
assessed by incubating venom with varying amounts of antivenom at antivenom:venom ratios 
of 1:1.5, 3:1.5 and 10:1.5 (v/w). These ratios were based on the manufacturer´s stated 
neutralizing capacity for the antivenom (1 ml of antivenom neutralizes 1.5 mg of M. frontalis 
venom). The venom was either pre-incubated with the desired volume of antivenom at 37 oC 
for 30 min before assaying for residual neuromuscular activity (Gutiérrez et al., 2017), or the 
required volume of antivenom was added directly to the organ bath after 50% or 80% 
blockade had been reached so as to assess the reversal of blockade.  The venom of M. 
frontalis, which is included in the venom pool used to raise coral snake antiserum in horses 




Mouse sciatic nerve compound action potentials (CAPs) were recorded from a 3-6 cm 
length of sciatic nerve comprising the proximal and distal regions. The nerve was dissected 
and mounted in a Perspex recording chamber containing physiological salt solution 
(composition, in mM: NaCl 150, KCl 5.4, HEPES 10, NaHCO3 12, KH2PO4 0.4, MgCl2 1.2, 
CaCl2 1.8 and glucose 10, pH 7.3-7.4) previously gassed with 100 % O2 (Dal Belo et al., 
2005; Floriano et al., 2015). Standard extracellular recording techniques were used to record 
CAPs via pellet-type Ag/AgCl electrodes dipped into two of the chambers. CAPs were 
evoked by placing two platinum wires into the end chamber and attaching them to a Grass 
S48 stimulator via a stimulus isolation unit (SIU 5A) to supply supramaximal voltages (0.4 
Hz, 0.05 ms duration) (Grass Instruments). The signals were amplified by an Electro 705 
electrometer (World Precision Instruments, Sarasota, FL, USA) and Tektronix 5A22N 
transducer (Tektronix, Beaverton, OR, USA) and digitized through an A/D BCN-2110 card 
(National Instruments, UK). CAPs were recorded and analyzed using custom-built software 
(WinWCP v.4.5.7) (Dempster, 1988). In each experiment, the amplitude, rise time and 
latency of the CAPs were measured. Prior to adding venom, the CAP amplitude was 
monitored for 15 min (pre-treatment control period); if the CAP amplitude decreased by more 
than 10% of the initial value during this period the nerve was remounted and a new 
equilibration period was initiated. To verify whether the nerve was desheathed, tetrodotoxin 
(TTX, 1 M) was added at the end of the experiments (in the absence of complete blockade 
by venom).  
 
Intracellular recordings 
The effects of venom on the frequency and amplitude of miniature end-plate potentials 
(MEPPs), quantal content (QC) from evoked end-plate potentials (EPPs) and membrane 
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resting potential (RP) were recorded using mouse PND preparations mounted in a Perspex 
Sylgard-coated chamber containing Tyrode solution (composition in section 2.4.2), 
essentially as described elsewhere (Floriano et al., 2013). To measure the MEPPs, EPPs and 
RP, a microelectrode (15-20 M) filled with KCl (3 M) was positioned on one muscle fiber 
near the endplate region and the signals were amplified, digitized and analyzed as described 
in section 2.5. The QC was estimated as the quotient between the squared average and the 
variance of the EPPs (indirect method) (McLachlan and Martin, 1981) using the software 
WinWCP v.4.5.7 (Dempster, 1988). The MEPP frequency was monitored in multiple 
neuromuscular junctions at t0 (zero time, pre-venom basal value) and at various times after 
venom addition (t5-t60). RP measurements were obtained from different regions of the muscle 
at the same intervals as the MEPP frequency determinations. To assess the functionality of 
postsynaptic nicotinic receptors (absence or presence of blockade by venom neurotoxins), a 
single concentration of carbachol (CCh, 68.5 M) was added prior to the venom and 15 min 
later the level of membrane depolarization was recorded followed by washing of the 
preparation; the same procedure was repeated at the end of the incubation with venom.  All of 
the electrophysiological protocols were done at room temperature. 
 
Morphological analysis  
Samples of mouse hemidiaphragm were fixed in 10% formaldehyde, dehydrated in an 
increasing ethanol series, cleared in xylol and embedded in paraffin. Serial sections 5 µm 
thick were obtained from the mid-region of the muscle using a Leica RM2245 microtome. 
The sections were stained with hematoxylin-eosin (HE) and examined with a Leica DFC 






All results (myographic and electrophysiological) were expressed as the mean ± SEM 
of the number of independent experiments (preparations) indicated in the text and figure 
legends. Changes in the twitch-tension responses of BC and PND preparations were 
expressed as a percentage relative to baseline (time zero) values. Statistical comparisons were 
done using Student's t-test or ANOVA followed by the Tukey-Kramer test, with p < 0.05 
indicating significance. All data analyses were done using Microcal Origin 8 SR4 v.8.0951 
(Microcal Software Inc., Northampton, MA, USA) or GraphPad Prism 5 (GraphPad Software 
Inc., San Diego, CA, USA) software. 
 
Results 
Venom PLA2 activity and inhibition by p-BPB 
Micrurus l. lemniscatus venom exhibited PLA2 activity (4.56 ± 0.02 nmol/min/mg at 
37 ºC, n = 3) that was attenuated by 33 ± 0.2% when the assay was done at 25 °C (3.07 ± 0.1 
nmol/min/mg, p < 0.05, n = 3) (Fig. 2A). In low (0.36 mM) and nominal zero Ca2+ buffer, the 
activity at 37 ºC was attenuated by 60 ± 0.1% and 73 ± 0.2%, respectively; a similar profile of 
attenuation was seen when the assay was done at 25 oC. However, proportionally, the 
reduction in enzyme activity in low and nominal zero Ca2+ conditions was greater for activity 
measured at 37 oC than at 25 oC, although in absolute values there was no significant 
difference in the activities observed in these two Ca2+ conditions at both temperatures. Pre-
incubation with p-BPB significantly reduced the PLA2 activity of the venom [from 4.59 ± 






Neuromuscular effects of venom in BC preparations 
In BC preparations, M. l. lemniscatus venom (0.1-30 µg/ml) caused concentration-
dependent neuromuscular blockade that was maximal at 10 µg/ml, with complete blockade 
occurring at concentrations ≥1 µg/ml between 20-40 min after venom addition. However, all 
venom concentrations caused a significant decrease in twitch amplitude at the end of the 60 
min incubation (Fig. 3A). This concentration-dependent blockade was evident in the times 
required for 50% and 90% blockade, which decreased progressively with increasing venom 
concentration, except for the two highest concentrations for which the times were similar at 
each level of blockade (Table 1). Figure 3B provides a representative recording of the 
neuromuscular blockade induced by the venom (10 g/ml) in an indirectly stimulated 
preparation at 37 °C and shows that the blockade was not reversible by repeated washing of 
the preparation; there was also no increase in baseline tension normally associated with 
muscle contracture. Muscle contractions to exogenous ACh and CCh were completely 
abolished at venom concentrations ≥0.1 µg/ml onwards, indicating interaction of venom 
neurotoxins with extrajunctional postsynaptic nicotinic receptors. However, the venom did 
not significantly alter the contractures to KCl (101 ± 4.9%, 88.5 ± 8.8%, 90.9 ± 3.1%, 102.2 ± 
4.8%, 103.8 ± 9.8% and 109.3 ± 0.2% for 0.1, 0.3, 1, 3, 10 and 30 µg of venom/ml, 
respectively, expressed as a percentage of the contracture to KCl prior to venom addition, 
considered as 100%; n = 4 each), thus indicating the lack of a direct effect on muscle 
contractility. 
 
Neuromuscular effects of venom in PND preparations 
In PND preparations, M. l. lemniscatus venom caused irreversible time- and 
concentration-dependent neuromuscular blockade from 3 µg of venom/ml onwards, although 
only 10 and 30 µg/ml caused complete blockade in <60 min (52 ± 2.3 min and 17 ± 1.3 min, 
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respectively, with the higher concentration causing significantly faster blockade; p < 0.05, n = 
4-5) (Fig. 4A). This time- and concentration-dependence was evident in the times required for 
50% and 90% blockade, which decreased progressively with increasing venom concentration 
(Table 1). Figure 4B shows representative recordings of the complete neuromuscular 
blockade induced by 10 µg/ml (B1) and 30 µg/ml (B2) in ~55 and ~15 min, respectively, that 
was not reversed by washing the preparations. As with BC preparations, the venom did not 
cause an increase in the baseline tension. The venom (10 and 30 g/ml) also did not cause a 
decrease in muscle twitch tension in directly-stimulated PND preparations pre-treated with d-
Tc (14.7 M), indicating the lack of a direct effect on muscle contractility [twitch responses 
after a 60 min incubation: 87.8 ± 3.4%, 88.3 ± 1.7% and 87.2 ± 1.2% of basal values 
(considered as 100%) for control (Tyrode solution alone), 10 and 30 µg of venom/ml, 
respectively, n = 4 each]. Slight, transient facilitation (9.6 ± 1.4% above basal twitch 
response; n = 4) was seen within 10-20 min after the addition of venom in directly stimulated 
preparations incubated with 30 g of venom/ml. Figure 4B3 shows the initial neuromuscular 
facilitation and the lack of blockade by the venom (30 µg/ml) in a curarized, directly 
stimulated PND preparation. Based on the results described above, a venom concentration of 
10 g/ml was chosen for subsequent experiments with PND preparations as this was the 
lowest concentration that caused complete blockade in <60 min. The neuromuscular blockade 
caused by venom (10 g/ml) was accompanied by an equally rapid inhibition of the tetanic 
response to electrical stimulation, but without significant tetanic fade (Supplementary Fig. 1); 
this inhibition was considerably faster than that observed with the venom of M. frontalis, used 
for comparison (t50 for blockade of PND muscle twitches by 10 g of M. frontalis venom/ml: 
32 ± 3.8 min (n = 4), which was greater (p < 0.05) than the corresponding time for blockade 
by M. l. lemniscatus (Table 1); t50 for blockade of tetanic twitches by M. l. lemniscatus and M. 
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frontalis venoms was 50 ± 2.5 min (n = 4) and 20 ± 2.2 min (n = 4), respectively; p < 0.05) 
(Supplementary Fig. 1).        
The M. l. lemniscatus venom (10 g/ml)-induced neuromuscular blockade was not 
prevented by pre-treatment with p-BPB but there was a significant delay in the times required 
for 90% blockade [28 ± 1.1 min (positive control - ethanol) vs. 37 ± 1.4 min (p-BPB-treated 
venom), p < 0.05, n = 3]; the change in the time for 50% blockade was not significant [14 ± 
1.2 min (positive control - ethanol) vs. 18 ± 1.8 min (p-BPB-treated venom), n = 3] (Fig. 4C).  
Histological analysis of diaphragm muscle at the end of the experiments revealed little 
muscle damage, in agreement with the lack of increase in baseline tension and the unaltered 
contractile responses in directly stimulated PND preparations (Supplementary Fig. 2).    
 
Neuromuscular effects of venom in PND preparations maintained in low Ca2+ physiological 
solution 
To examine whether M. l. lemniscatus venom exhibited PLA2-independent actions, as 
commonly seen in other Elapidae venoms that contain -neurotoxins, some experiments were 
done in low Ca2+ physiological solution to reduce the PLA2 activity of the venom. Under 
these conditions, and before adding venom, there was a decrease in twitch amplitude as a 
result of a reduction in quantal content and the consequent failure of motor units. 
When PND preparations were maintained in low Ca2+ physiological solution (0.36 
mM) under indirect stimulation, the venom (10 g/ml) caused rapid neuromuscular blockade 
that was complete in 20 ± 2.5 min (n = 5); this concentration of venom caused complete 
blockade in 52 ± 2.3 min (n = 5) in preparations maintained in normal Ca2+ conditions (1.8 
mM) (Fig. 5A). When the preparations were washed with physiological solution containing 
normal Ca2+ (1.8 mM) immediately after total neuromuscular blockade in low Ca2+ conditions 
there was immediate and complete reversal of the blockade to the level of contractility seen 
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before venom addition; recovery of contractility to the level seen before incubation in low 
Ca2+ required several washes with normal Ca2+ solution (Fig. 5B1). There was no reversal of 
the blockade when the preparations were initially washed with low Ca2+ (0.36 mM) 
physiological solution, but subsequent washing with normal Ca2+ solution restored the 
neurotransmission (Fig. 5B2).  The addition of Ca
2+ (1.8 mM) immediately after venom-
induced blockade (with no prior washing of the preparation to remove the venom, in contrast 
to Fig. 5B1 in which there was washing with normal Ca
2+ solution to remove venom) caused a 
transient increase in twitch amplitude that was followed by complete, irreversible blockade 
(Fig. 5B3); adding a high concentration of Ca
2+ (10 mM), the twitch responses were 
temporary recovered similarly to that seen with 1.8 mM Ca2+ (Fig. 5B4). 
 
Influence of neostigmine and 3,4-diaminopyridine on the venom-induced blockade in PND 
preparations 
In PND preparations maintained under normal Ca2+ conditions (1.8 mM), neostigmine 
(NEO, 29 µM) and 3,4-diaminopyridine (3,4-DAP, 230 µM) did not restore muscle 
contractility after complete venom (10 µg/ml)-induced neuromuscular blockade (Fig. 6A1-
A2). However, in preparations incubated in low Ca
2+ conditions, NEO caused a small, 
transient reversal of the venom (10 µg/ml)-induced neuromuscular blockade [maximum 
reversal of 28 ± 3.5% relative to the basal contractile responses in low Ca2+ basal values 
(considered as 100%); this reversal was maximal in 2.2 ± 0.08 min; n = 4]; the addition of 
Ca2+ (1.8 mM) after incubation with NEO for 10 min resulted in partial temporary restoration 
of the twitch responses (maximum reversal of 102 ± 21% that was reached in 4.1 ± 0.3 min; n 
= 4) followed by irreversible blockade 14 ± 1.1 min after the maximum response (Fig. 6B1). 
3,4-DAP (230 µM) produced greater reversal of the venom (10 µg/ml)-induced 
neuromuscular blockade compared to that seen with NEO (maximum reversal of 300 ± 37% 
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that was reached in 5.5 ± 0.4 min; n = 4); however, as with NEO, this reversal was transient, 
with complete blockade occurring 22 ± 0.8 min after reaching the maximum response. The 
addition of Ca2+ (1.8 mM) shortly after complete blockade in the presence of 3,4-DAP did not 
restore the muscle twitches, nor did repeated washing of the preparation (Fig. 6B2). 
For comparison, similar protocols run with the venom of M. frontalis, considered to be 
predominantly postsynaptic in action, yielded essentially the results as seen with M. l. 
lemniscatus, i.e., minimal reversal by NEO and 3,4-DAP in normal Ca2+, little reversal by 
NEO but a marked response to 3,4-DAP (~180%) in low Ca2+ solution, and 
temporary/transitory enhancement of muscle twitches with the addition of normal Ca2+ (~33% 
of twitch responses in low normal Ca2+; Supplementary Figs. 3 and 4). 
 
Effect of venom on the membrane resting potential, miniature end-plate potentials and evoked 
end-plate potentials in mouse PND preparations  
Micrurus l. lemniscatus venom (10 g/ml) did not affect the membrane resting 
potential (RP) of diaphragm muscle as there was no depolarization of the muscle membrane 
during a 60 min incubation [RP: -79.4 ± 1.7 mV (t0) vs. -82.3 ± 0.5 mV (t60), n = 5] and did 
not affect carbachol (CCh)-induced depolarization (responses to CCh before and after venom:  
-58 ± 6 mV and -59.5 ± 8.7 mV, respectively; n = 5) (Fig. 7), indicating a lack of myotoxicity 
(unaltered RP) and no interference with postsynaptic receptors (unaltered response to CCh).  
Venom (3 g/ml) caused a biphasic change in MEPP frequency that involved an initial  
increase in neurotransmitter release 5-15 min after venom addition followed by a progressive 
decrease from 45 min onwards (Table 2); this biphasic effect was particularly marked in 
MEPPs with amplitudes of 0.6-2.0 mV (Fig. 8). There was also a significant decrease in 
MEPP amplitude during both the excitatory and inhibitory phases (t5 and t45, respectively) 
(Table 2). In these experiments and in the EPP measurements described below, a venom 
18 
 
concentration of 3 g/ml was used as this gave a clearer response than a concentration of 10 
g/ml.  
Fig. 9A1 and A2 show representative recordings of the changes in EPP amplitude in 
control (Tyrode solution) and venom-treated (3 g/ml) preparations, respectively; note that of 
six preparations studied, only the one indicated in Fig. 9A2 showed an excitatory phase of 
neurotransmitter release (at 5 min after venom addition). Fig. 9B shows that incubation with 
venom (3 g/ml) resulted in a significant decrease in EPP amplitude from 30 min onwards.   
 
Effect of venom on the compound action potential recorded in mouse sciatic nerve 
preparations 
Incubation with venom (3, 10 and 30 µg/ml) did not affect neuronal conduction 
assessed through compound action potential (CAP) measurements in mouse sciatic nerve 
preparations (Fig. 10); there was a slight, non-significant decrease in CAP amplitude at the 
two highest venom concentrations (10 and 30 g/ml), with no important alterations in the 
latency and rise time of the potentials (Table 3). Tetrodotoxin (TTX, 1 M) added at the end 
of the experiments abolished the CAP, indicating that sodium channels were not affected by 
the venom. 
 
Neutralization of neuromuscular blockade by coral snake antivenom in PND preparations   
The neuromuscular blockade induced by M. l. lemniscatus venom (10 g/ml) was not 
significantly attenuated by pre-incubating venom with the manufacturer´s recommended 
antivenom:venom ratio of  1:1.5 [the t50 (in min) for blockade in the absence and presence of 
antivenom was 20 ± 4.4 and 24 ± 4.1, and complete blockade occurred in 53 ± 3.9 min and  
62 ± 4.3 min, respectively; n = 4]. Pre-incubation with a higher antivenom:venom ratio 
(3:1.5) produced partial neutralization, with neuromuscular blockade reaching a maximum of 
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91 ± 4.2% after a 120 min incubation; complete neutralization occurred at an 
antivenom:venom ratio of 10:1.5 (Fig. 11A). In contrast to these findings, similar experiments 
with M. frontalis venom (positive control) resulted in complete neutralization of the 
neuromuscular activity at all of the antivenom:venom ratios tested, including the 
recommended ratio of 1:1.5 (Fig. 11B). 
The addition of antivenom after venom-induced blockade had reached 50% and 80% 
was also effective in reversing the neuromuscular blockade and restoring the muscle 
contractility. At the recommended antivenom:venom ratio of 1:1.5 the reversal of 50% and 
80% blockade by M. l. lemniscatus venom was 53.2 ± 2.7% and 39.2 ± 2.1% (n = 4) after the 
first addition of antivenom. Two further additions of antivenom (at the same 
antivenom:venom ratio) were required to achieve complete reversal of the blockade in 
preparations with 50% blockade, while in preparations with 80% blockade the recovery was 
still <100% after the third addition (Fig. 12). With M. frontalis venom, the first application of 
antivenom resulted in 69.4 ± 2.3% reversal after 50% blockade and 52.4 ± 2.3% reversal after 
80% blockade; the reversal in both of these cases was greater that the corresponding reversal 
with M. l. lemniscatus venom. A second application of antivenom resulted in full reversal 
after 50% blockade, whereas a third application was required to achieve full recovery after 
80% blockade.  Overall, reversal of the neuromuscular blockade was easier with M. frontalis 
than with M. l. lemniscatus venom. These findings indicate that while antivenom was able to 
restore neurotransmission after the onset of blockade, more antivenom was required than 
suggested by the pre-incubation protocols or by the manufacturer´s recommended 
antivenom:venom ratio. Furthermore, the reversal experiments indicated that the greater the 
neuromuscular blockade prior to antivenom administration, the more difficult it was to restore 
neurotransmission. This finding agrees with clinical observations regarding the difficulty in 
20 
 
reversing neuromuscular blockade with antivenom in patients with manifestations of severe 
neurotoxicity (Bucaretchi et al., 2016a).    
The addition of antivenom corresponding to an intermediate antivenom:venom ratio of 
3:1.5 (without prior addition of the lower antivenom:venom ratio of 1:1.5) produced 70 ± 
3.4% and 61 ± 4.1% of reversal after 50% and 80% blockade, respectively (n = 4), with two 
further additions of this ratio resulting in a final reversal of 120 ± 4.7% and 109±3.1% after 
50% and 80% blockade, respectively. The highest antivenom:venom (10:1.5) produced 
complete reversal of the twitches responses (105 ± 3.8% and 99 ± 4.2% for 50% and 80% 
blockade, respectively) with just a single addition. Against M. frontalis venom, the addition of 
antivenom at the intermediate antivenom:venom ratio (3:1.5) completely restored the twitch 
tension responses after 50% and 80% blockade (recordings not shown). In view of the 
complete reversal obtained with the latter ratio, the highest antivenom:venom ratio (10:1.5) 
was not tested with this venom. 
 
Discussion  
Systemic envenomation by coral snakes (Micrurus spp.) in humans is characterized by 
neurotoxicity (Bucaretchi et al., 2016a,b; Risk et al., 2016; Anwar and Bernstein, 2017; 
Corbett and Clark, 2017) and various studies have confirmed this neurotoxicity in vivo (Vital 
Brazil, 1965; Weis and McIssac, 1971; Vital Brazil et al., 1976/77; Vital Brazil and Fontana, 
1983/84) and in vitro (Vital Brazil et al., 1976/77; Vital Brazil and Fontana, 1983/84; 
Goularte et al., 1995; Vital Brazil et al., 1995; Abreu et al., 2008, Camargo et al., 2011; 
Renjifo et al., 2012; Carbajal-Saucedo et al., 2014; Yang et al., 2017). The results described 
here show that, in common with other Micrurus spp., M. l. lemniscatus venom caused 
irreversible blockade of neurotransmission in mammalian and avian neuromuscular 
preparations. Mouse PND preparations were less sensitive to neuromuscular blockade than 
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chick BC preparations, as reflected in the times required for 50% and 90% blockade (Figs. 3 
and 4, Table 1): in the former, venom caused complete blockade at concentrations ≥3 g/ml, 
while in the latter complete neuromuscular blockade occurred at ≥1 g/ml. This interspecific 
variation in sensitivity to neuromuscular blockade has been noted for other coral snake 
venoms (Cecchini et al., 2005; Abreu et al., 2008; Camargo et al., 2011; Carbajal-Saucedo et 
al., 2014) and probably reflects differences in the mode of innervation of these two 
preparations, i.e., monofocal in mammalian and multifocal in avian muscle, in addition to the 
presence of extra-junctional nicotinic receptors (nAChR) in the avian preparation (Chang and 
Tang, 1974; Chang and Su, 1975; Silva et al., 2017).  
 
Mechanism of blockade 
  The neurotoxicity of Micrurus venoms is mediated by a combination of postsynaptic 
-neurotoxins and presynaptic -neurotoxins (Gutiérrez et al., 2016; Lomonte et al., 2016; 
Aird et al., 2017), and proteomic and transcriptomic studies have shown that the venoms of 
M. l. carvalhoi and M. l. lemniscatus contain a variety of - and -neurotoxins (Ciscotto et 
al., 2011; Aird et al., 2017). We therefore sought to assess the relative contribution of these 
two groups of toxins to the blockade caused by M. l. lemniscatus venom.  
In BC preparations, the contractures induced by exogenous ACh and CCh were 
abolished by venom concentrations ≥0.1 µg/ml, indicating the presence of -neurotoxins in 
the venom. The sensitivity of the post-junctional receptors to blockade by -neurotoxins was 
quite high since venom concentrations of 0.1 and 0.3 g/ml abolished the responses to 
exogenous ACh and CCh while causing only partial neuromuscular blockade in indirectly 
stimulated preparations after a 60 min incubation. Thus, although venom blocked the extra-
junctional postsynaptic receptors at low concentrations, the junctional postsynaptic receptors 
of the end-plate region remained responsive.  
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In PND preparations, the blockade at a venom concentration of 10 g/ml was 
accompanied by a rapid progressive decrease in the tetanic muscle contractures but without 
tetanic fade. A decrease in tetanic contractures has also been reported for M. pyrrhocryptus 
venom at the same concentration (10 g/ml) as used here for M. frontalis and M. l. 
lemniscatus.  In his seminal study of the neuropharmacology of Micrurus venoms, Vital 
Brazil (1965) found that the neuromuscular blockade caused by ‘M. lemniscatus’ (=M. l. 
carvalhoi) venom in rat PND preparations was partially reversed by neostigmine, a finding 
suggestive of a predominantly postsynaptic action.  However, as shown here for mouse PND 
preparations, the M. l. lemniscatus venom-induced blockade was not reversed by neostigmine 
or 3,4-DAP in normal Ca2+ solution. We also observed similar minimal reversal of the 
blockade caused by the venom of M. frontalis that has a predominantly postsynaptic action 
(Vital Brazil et al., 1976/77). This lack of reversal could reflect (a) very high affinity 
(‘irreversible’) binding of -neurotoxins to nAChR, (b) the fact that these compounds were 
tested only after complete blockade, when reversal can be very limited (Goularte et al., 1995), 
and (c) a general refractoriness of rodent preparations to the reversal of coral snake venom-
induced blockade. Indeed, the reversal of Micrurus venom-induced blockade in rodent PND 
preparations rarely exceeds 30-50% and is transient, with subsequent progression to complete 
neuromuscular blockade (Goularte et al., 1995; Vital Brazil et al., 1995; Serafim et al., 2002; 
Abreu et al., 2008; Camargo et al., 2011; Renjifo et al., 2012). This finding contrasts with the 
complete reversal by neostigmine of the blockade caused by M. frontalis venom in vivo in 
pigeons, dogs and monkeys (Vital Brazil, 1987) and humans (Vital Brazil and Vieira, 1996). 
A further possibility for the limited reversal by neostigmine and 3,4-DAP could be 
that the blockade was mediated by a predominantly presynaptic rather than postsynaptic 
action (Vital Brazil, 1987). Indeed, the finding that CCh-induced depolarization of diaphragm 
muscle was not prevented by prior incubation with the venom for 60 min (enough time for 
23 
 
venom-induced neuromuscular blockade at the concentration tested – 10 g/ml) indicated that 
postsynaptic nAChR were not blocked by the venom. Clinically, the inability of neostigmine 
to reverse coral snake venom-induced neuromuscular blockade has also been considered 
indicative of a predominantly presynaptic action (Vital-Brazil and Vieira, 1996; Manock et 
al., 2008; Bucaretchi et al., 2016a).   
This conclusion regarding a presynaptic action was supported by changes in the MEPP 
frequency that showed a biphasic response consisting of an initial excitatory phase at ~15 min 
(corresponding to ACh release) followed by an inhibitory phase, leading to blockade. A 
similar response has been reported for M. laticorallis venom (Carbajal-Saucedo et al., 2014) 
and this phenomenon is characteristic of elapid presynaptic neurotoxins (Chang et al., 1977; 
Chang and Su, 1982; Pungerčar and Križaj, 2007; Rossetto and Montecucco, 2008; Šribar et 
al., 2014). This biphasic ACh release was not seen in evoked EPPs (although the venom 
caused a significant reduction in neurotransmitter release) or in twitch-tension experiments 
under low Ca2+ conditions. The lack of effect on compound action potentials from mouse 
sciatic nerve preparations confirmed that the neuromuscular effect of M. l. lemniscatus venom 
was restricted to the motor end-plate where it affected the presynaptic mechanisms of ACh 




Micrurus venoms, including those of M. l. carvalhoi and M. l. lemniscatus contain 
numerous PLA2 (Ciscotto et al., 2011; Lomonte et al., 2016; Aird et al., 2017) that can 
potentially contribute to neuromuscular blockade in experimental animals and humans 
(Vergara et al., 2014). However, relatively few of these enzymes have been purified and their 
neurotoxicity assessed pharmacologically (Dal Belo et al., 2005).  Oliveira et al. (2008) 
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reported that the intracerebroventricular injection of several PLA2 purified from M. l. 
carvalhoi venom in rats resulted in a range of behavioral, electroencephalographic, and 
morphological alterations as well as lethality (at doses of ~4.4-17 g/kg), whereas these 
enzymes were not lethal when administered intravenously at up to ~1.6 mg/kg in mice. 
Carvalho et al. (2014) examined the cytotoxicity of some of these same PLA2 in rat cultured 
hippocampal neurons, and more recently, Casais-e-Silva et al. (2016) described the 
myotoxicity and pro-inflammatory activity of lemnitoxin, a PLA2 from M. l. carvalhoi 
venom.  
As shown here, M. l. lemniscatus venom had PLA2 activity, in agreement with this 
activity previously reported for M. lemniscatus ssp. venoms (Aird and Silva Jr., 1991). The 
PLA2 activity was significantly reduced when assayed in low Ca
2+ and at room temperature 
(25 oC) and after preincubation with p-bromophenacyl bromide (p-BPB), a widely used 
inhibitor of snake venom PLA2 activity (Lomonte et al., 2003; Soares and Giglio, 2003).  
Although these interventions attenuated the PLA2 activity, they caused only a slight rightward 
shift in the time curves for venom (10 g/ml)-induced blockade in PND preparations; there 
was a slight delay (~10 min) in the onset of blockade and a small increase (also ~10 min) in 
the time for complete blockade. The exception to this trend was low Ca2+ solution that 
considerably potentiated the onset and time for total blockade. These findings indicate that 
PLA2 activity, a temperature of 37 
oC and the presence of Ca2+ are not essential for the 
venom-induced blockade.  Overall, these results suggest that PLA2 may not have a central role 
in this venom-induced blockade or possibly that non-catalytic PLA2 (not detected in the 
enzymatic assay) may be more important in this response. Catalytic and non-catalytic PLA2 
have been detected in transcriptomic analysis of M. l. lemniscatus venom (Aird et al., 2017). 
Neuromuscular blockade that is independent of Ca2+ and unaffected by a reduction in 
temperature (and, by inference, PLA2 activity) has also been reported for the venoms of M. 
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altirostris (Abreu et al., 2008) and M. pyrrhocryptus (Camargo et al., 2011). In contrast, the 
neuromuscular blockade caused by venoms that are myotoxic, such as that of M. nigrocinctus 
(Goularte et al., 1995), is markedly attenuated by a reduction in temperature.  
 
Role of calcium 
In indirectly-stimulated PND preparations maintained in low (0.36 mM) Ca2+ Tyrode 
solution, M. l. lemniscatus venom produced potent neuromuscular blockade in <20 min 
compared to ~50 min in normal Ca2+ (1.8 mM) solution. Incubation in low Ca2+ physiological 
solution reduced twitch amplitude by decreasing the release of ACh, with consequent 
deactivation of motor units. In these conditions, the few remaining responsive motor units 
were rapidly blocked by the venom neurotoxins. When the preparations were washed with 
Tyrode solution containing normal Ca2+ (1.8 mM) immediately after complete neuromuscular 
blockade, there was total recovery of the twitch responses; no such recovery was seen when 
the preparations were washed with low Ca2+ Tyrode solution. However, the addition of 1.8 
mM Ca2+ to the bath once blockade had been achieved resulted in temporary recovery of the 
twitch responses followed by complete, irreversible blockade. This observation suggested the 
possibility that Ca2+ was involved in modulating the blockade. To examine the latter 
possibility, the effect of adding 10 mM Ca2+ to the organ bath once blockade had been 
achieved was examined; this concentration of Ca2+ produced a temporary recovery of the 
twitch responses similar to that seen with 1.8 mM Ca2+ (data not shown). 
These results suggest that by re-establishing the ideal Ca2+ concentration for normal 
presynaptic release of ACh, the enhanced presence of neurotransmitter in the synaptic cleft 
could displace postsynaptic toxins that were blocking nicotinic receptors, resulting in the 
restoration of twitch responses. Alternatively, this enhanced response to restored Ca2+ could 
simply represent an increase in the EPP amplitude of motor units that were previously set at 
Favor, checar esta questão 
novamente porque aqui 
estamos falando do veneno 
de M. l. lemniscatus, e não 
do de M. frontalis. Chequei 
as Figs. Suplementares (esp. 
Fig. 4C), mas isso não trata 
do veneno de M. frontalis. 
Você tem estes dados para 
M. l. lemnisctus? (As Figs. 5 
e 6 não contem esta 
informação. Se for o caso, 
poderia acrescentar mais um 
registro, como painel B3, 
para mostrar isso na Fig. 6.)  
Favor, checar este trecho em azul, que foi uma explicação alternativa sugerida pelo Prof. 
Eddie. Veja se faz sentido e se está correto assim – também ver se faz ‘ligação’ com o 
texto que vem depois. 
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slightly below threshold but were now contributing to the twitch responses. When the 
preparations were maintained in low Ca2+ and subsequently exposed to M. l. lemniscatus 
venom, there was no damage to the pre- and postsynaptic machinery involved in motor 
neurotransmission. On the other hand, when Ca2+ (1.8 mM) was added directly to the bath 
physiological solution after complete blockade, there was a transient reversal of the twitch 
responses that subsequently progressed to complete, irreversible neuromuscular blockade in 
~30 min, a time scale similar to that for preparations exposed to venom in normal Ca2+ 
conditions.  
As indicated above, neostigmine and 3,4-DAP failed to reverse the venom-induced 
blockade in PND preparations in normal Ca2+ solution. However, in low Ca2+ conditions, the 
neuromuscular blockade was temporarily reverted by 3,4-DAP followed by irreversible 
blockade, indicating that the machinery involved in ACh release was not affected by the 
venom. The irreversible blockade seen after the 3,4-DAP-induced facilitation probably 
resulted from the depletion of synaptic vesicle stores subsequent to the enhanced entry of Ca2+ 
into the motor nerve terminal. The very poor response to neostigmine in low Ca2+ conditions 
largely reflected the mode of action of this compound in enhancing the synaptic content of 
neurotransmitter rather than stimulating the presynaptic release of ACh.  
 
Myotoxicity 
Myotoxicity has been demonstrated experimentally in mice for a variety of Micrurus 
spp. venoms (Gutiérrez et al., 1980, 1983, 1992), but is rarely seen clinically, mainly in M. 
fulvius from southeastern United States (Kitchens and Van Mierop, 1987; Bucaretchi et al., 
2016b). Although M. lemniscatus spp. venoms contain PLA2 (Silva Jr. and Aird, 1991; 
Cecchini et al., 2005; Oliveira et al., 2008; Carvalho et al., 2014; Casais-e-Silva et al., 2016; 
Aird et al., 2017), several lines of evidence from the present investigation indicated that M. l. 
Você tem alguma referência para apoiar esta afirmação?  Você fez experimentos controles com apenas DAP (ou seja, DAP 
sozinha em uma preparação, sem incubação prévia com veneno) para ver se a facilitação com DAP era mantida ou se 
decaía? (Este controle seria importante para afirmar que o bloqueio irreversível visto após DAP era devido à depleção dos 
estoques de neurotransmissor). 
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lemniscatus venom was not myotoxic and that myotoxicity was not a contributing factor to 
the neuromuscular blockade observed here. Specifically, (1) the venom had no effect on 
muscle contractility in curarized, directly stimulated PND preparations (a venom 
concentration of 30 g/ml had no effect in this preparation but produced complete blockade in 
~20 min in indirectly stimulated preparations), (2) there was no increase in the baseline 
tension (indicative of muscle contracture) in either BC or PND preparations, (3) the venom 
did not depolarize the diaphragm muscle membrane, (4) the contractile responses to 
exogenous K+ (generally used as an indicator of venom and toxin-induced myotoxicity;  
Harvey et al., 1994) were unaltered in BC preparations, even when the responses to ACh and 
CCh had been abolished, and (5) histological analysis revealed no muscle necrosis or general 
damage. These findings are reminiscent of those reported by Vital Brazil (1965, 1987) for ‘M. 
lemniscatus’ (=M. l. carvalhoi), the venom of which also did not affect the contractile 
responses to direct muscle stimulation or depress the muscle contractures to exogenous K+ in 
rat chronically denervated rat hemidiaphragm; a similar lack of myotoxicity has also been 
observed for other species such as M. altirostris (Abreu et al., 2008) and M. pyrrhocryptus 
(Camargo et al., 2011). In contrast, the venoms of M. dissoleucus from Colombia (Renjifo et 
al., 2012), M. laticorallis from Mexico (Carbajal-Saucedo et al., 2014) and M. nigrocinctus 
from Costa Rica (Goularte et al., 1995, 1999) are myotoxic and produce neuromuscular 
blockade and an increase in baseline tension in PND preparations in vitro. 
 
Neutralization by antivenom 
Antivenom therapy is the mainstay for treating systemic envenomation by coral snakes 
and its early administration is important in preventing or reversing neuromuscular blockade 
since antivenom is considerably less effective once full neuromuscular blockade has been 
established (Bucaretchi et al., 2016a,b). The coral snake antivenom produced in Brazil by the 
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Instituto Butantan (São Paulo) and Fundação Ezequiel Dias (FUNED, Belo Horizonte, MG) is 
raised in horses against a combination of M. corallinus and M. frontalis venoms, with 1 ml of 
antivenom neutralizing 1.5 mg of M. frontalis venom. Although raised against the venom of 
only two of the numerous coral snake species in Brazil, this antivenom is used to treat 
envenoming by any of the other Micrurus spp. in this country (Bucaretchi et al., 2016).  
Whilst various studies have examined the immunological cross-reactivity and neutralization 
of biological activities (including lethality) of coral snake venoms with this antivenom 
(Higashi et al., 1995; Tanaka et al., 2010, 2016; Ramos et al., 2017), few have assessed its 
ability to neutralize the neuromuscular blockade caused by these venoms.   
Camargo et al. (2011) showed that Instituto Butantan antivenom neutralized the 
neurotoxicity of M. pyrrhocryptus venom from Argentina in BC preparations at the 
recommended antivenom:venom ratio, even though this venom is not included in the venom 
pool used in the immunization protocol.  In contrast, Abreu et al. (2008) reported that in 
preincubation protocols or when added simultaneously with the venom this same antivenom 
failed to protect against the neuromuscular blockade by M. altirostris venom in BC 
preparations at the recommended antivenom:venom ratio; complete protection against 
blockade and the reduction in contractures to exogenous ACh was obtained only at an 
antivenom:venom ratio 20-fold greater than the recommended ratio. For other Micrurus 
venoms, Goularte et al. (1995) showed that the neuromuscular blockade by M. nigrocinctus 
venom in PND preparations was prevented by an equine monovalent antivenom to this venom 
(produced by the Instituto Clodomiro Picado, Costa Rica), whether in preincubation protocols 
or when added 10-20 min after the venom. More recently, Yang et al. (2017) demonstrated 
that Coralmyn (Bioclon, Mexico), an equine antivenom raised against M. nigrocinctus 
nigrocinctus venom, effectively neutralized the neuromuscular blockade by M. fulvius venom 
in BC preparations, but was ineffective against the venoms of M. pyrrhocryptus, M. spixii, M. 
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tener and the Sonoran coral snake Micruroides euryxanthus.  None of these studies assessed 
the ability of antivenom to restore neurotransmission after ≥50% blockade. 
As shown here, in pre-incubation experiments, complete neutralization of the 
neuromuscular blockade caused by M. l. lemniscatus venom required a 10-fold higher 
antivenom:venom ratio than that recommended by the manufacturer, whereas complete 
neutralization of the neuromuscular blockade by M. frontalis venom was observed at the 
recommended antivenom:venom ratio. In agreement with these findings, the reversal of 
neuromuscular blockade when antivenom was added at the recommended antivenom:venom 
ratio after 50% or 80% blockade was more efficient against M. frontalis venom than against 
M. l. lemniscatus venom although, in both cases, more than one addition of antivenom was 
required and the extent of reversal was dependent on the initial degree of blockade. For both 
venoms, the higher the initial antivenom:venom ratio tested, the quicker the reversal of 
blockade, i.e., complete reversal of M. frontalis and M. l. lemniscatus blockade was achieved 
with a single addition of a three-fold and ten-fold higher initial antivenom:venom ratio, 
respectively.     
Although preincubation protocols are the gold standard for assessing antivenom 
neutralizing capacity in toxinology (Gutiérrez et al., 2017), the addition of antivenom after the 
onset of blockade such as used here is more representative of the clinical situation in which 
antivenom is given after envenomation. The results reported here suggest that the efficacy of 
antivenom in reversing neuromuscular blockade by M. l. lemniscatus venom in humans may 
be less than for M. frontalis, i.e., greater amounts of antivenom may be required to treat bites 
by the former species.  In addition, initiating treatment with an antivenom:venom ratio greater 
than that recommended by the manufacturer may hasten the recovery from neuromuscular 





Comparison of the neuromuscular effects of M. l. lemniscatus venom described here 
with the findings reported for M. l. carvalhoi (Vital Brazil, 1965; Cecchini et al., 2005) 
indicate that there are similarities (e.g., lack of myotoxicity, as shown by the inability to affect 
contractile responses to direct stimulation, membrane potential and contractures to exogenous 
K+) and potential differences (e.g., in the extent of reversibility of the venom-induced 
blockade by neostigmine) between the venoms of these two subspecies.  However, the lack of 
detailed neuromuscular and electrophysiological studies for the venoms of M. l. carvalhoi and 
M. l. helleri precludes further comparison among the subspecies.   
 
Conclusion 
The results of this study indicate that M. l. lemniscatus venom causes neuromuscular 
blockade by a combination of pre- and postsynaptic mechanisms, in agreement with the 
presence of - and -neurotoxins in the venom of this subspecies (Aird et al., 2017). The 
presence of presynaptic activity and the poor reversibility of blockade by neostigmine are 
reminiscent of those reported for M. corallinus (Vital Brazil and Fontana, 1983/84) and 
suggest that human envenomation by this species may not respond adequately to treatment 
with anticholinesterase drugs such as neostigmine (Bucaretchi et al., 2016b). This conclusion 
agrees with the clinical observation of a case of envenomation by the closely related M. l. 
helleri in which neostigmine was ineffective in reversing the neuromuscular blockade 
(Manock et al., 2008). In addition, the neutralization experiments indicated that while 
antivenom is useful in reversing the blockade by this venom, a 10-fold greater 
antivenom:venom ratio is required compared to that which protects against blockade by M. 
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Fig. 1. Distribution of M. lemniscatus subspecies in Brazil.  Note that all three subspecies also 
occur outside of Brazil. The range of M. diutius, recently separated from the M. lemniscatus 
complex (Starace, 2013), is also shown. Hatched areas – overlap between subspecies. “?” – 
regions of uncertainty with regard to distribution and potential overlap of subspecies. 
 
Fig. 2. PLA2 activity of M. l. lemniscatus venom. A. Influence of temperature and calcium 
concentration on enzymatic activity. B. Attenuation of enzymatic activity by p-BPB. Buffer 
(0.1 M ammonium bicarbonate, 0.7 mM EDTA, pH 8.0, used to incubate the venom with p-
BPB) and ethanol (solvent for p-BPB, final concentration 8.3%) were tested alone to examine 
their effect on enzyme activity. The columns are the mean ± SEM (n = 3). *p < 0.05 
compared to enzymatic activity at 37 °C and 10 mM Ca2+; #p < 0.05 compared to enzymatic 
activity at 25 °C and 10 mM Ca2+; †p < 0.05 compared to activity without p-BPB. 
 
Fig. 3. Neuromuscular activity of M. l. lemniscatus venom in chick biventer cervicis 
preparations. A. Twitch blockade caused by venom (0.1-30 µg/ml). B. Representative 
recording showing the irreversible blockade caused by venom (10 µg/ml) in a field stimulated 
preparation at 37 ºC. Note that contractures to exogenous ACh (1 mM, ▲) and CCh (20 µM, 
●) were abolished by the venom whereas those to KCl (40 mM, ■) were unaffected. In A, the 
points are the mean ± SEM (n = 4); *p < 0.05 compared to control preparations; w – wash. 
Scale bar in B: grams (g). 
 
Fig. 4. Neuromuscular activity of M. l. lemniscatus venom in mouse phrenic nerve-diaphragm 
preparations. A. Twitch blockade caused by venom (0.1-30 µg/ml). B. Representative 
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recordings showing the irreversible blockade caused by the venom (B1 – 10 µg/ml and B2 – 30 
µg/ml) in an indirectly stimulated preparation at 37 ºC, as well as the slight neuromuscular 
facilitation and lack of blockade in a curarized, directly stimulated preparation exposed to 30 
µg of venom/ml (B3). C. Neuromuscular blockade caused by venom pre-treated with p-BPB. 
Note that the inhibition of PLA2 activity had a minimal effect on the blockade. In A and C, 
the points are the mean ± SEM (n = 4-5). *p < 0.05 compared to control preparations; AB – 
ammonium bicarbonate buffer (see Fig. 2 legend for buffer composition), DS – direct 
stimulation, IS – indirect stimulation, d-Tc – d-tubocurarine, w – wash. Scale bars in B1-B3: 
grams (g). 
 
Fig. 5. Neuromuscular activity of M. l. lemniscatus venom in PND preparations maintained in 
low (0.36 mM) Ca2+ physiological solution. A. Comparison of the venom-induced blockade in 
normal (1.8 mM) and low Ca2+ physiological solutions. B. Representative recordings showing 
the immediate reversal of the venom-induced blockade after washing in normal Ca2+ 
physiological solution (B1), the lack of reversal during washing in low Ca
2+ conditions 
followed by immediate reversal when normal Ca2+ solution is used (B2), and the transient 
increase in twitch tension followed by irreversible blockade of the twitch response when 1.8 
mM Ca2+ was added to the bath immediately after neuromuscular blockade in low Ca2+ 
conditions (no removal of venom prior to addition of 1.8 mM Ca2+) (B3).  In (A), the points 
are the mean ± SEM (n = 4); *p < 0.05 compared to control preparations. Scale bars in B1-B3: 
grams (g). w – wash. 
 
Fig. 6. A. The lack of effect of neostigmine (NEO; 29 M, A1) and 3,4-diaminopyridine (3,4-
DAP; 230 M, A2) in reversing the neuromuscular blockade induced by M. l. lemniscatus 
venom (10 g/ml) in PND preparations in normal Ca2+ (1.8 mM) physiological solution. B. 
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Transitory reversal of venom (10 µg/ml)-induced blockade by NEO (29 M, B1) and 3,4-
DAP (230 M, B2) in low Ca2+ (0.36 mM) physiological solution. Note that when 1.8 mM 
Ca2+ was added at the end of both protocols (B1 and B2) partial restoration of muscle twitches 
was seen only after exposure to NEO. All representative recordings correspond to one of four 
experiments done at 37 °C.   
 
Fig. 7. Membrane resting potential recorded in PND preparations incubated with M. l. 
lemniscatus venom. The venom (10 µg/ml) did not cause membrane depolarization during a 
60 min incubation and also did not prevent carbachol (CCh)-induced depolarization at the end 
of the incubation. The columns are the mean ± SEM (n = 5). *p < 0.05 compared to basal 
values. 
 
Fig. 8. Frequency and amplitude of MEPPs recorded in PND preparations incubated with M. 
l. lemniscatus venom. Note that, with the exception of high amplitude MEPPs (≥2.6 mV), the 
other amplitude intervals showed an excitatory phase prior to the inhibitory phase in their 
frequencies. The columns are the mean ± SEM (n = 5) of MEPPs (frequency and amplitude) 
recorded at each interval. *p < 0.05 compared to basal values. 
 
Fig. 9.  End-plate potentials (EPPs) in PND preparations incubated with M. l. lemniscatus 
venom (3 g/ml). A. Superposed recordings showing the decrease in EPP amplitude caused 
by venom; the times for 0 (basal), 5, 15, 30, 45 and 60 min incubation are indicated close to 
their respective trace. S – stimulus artefact. A1 – Control preparation incubated with Tyrode 
solution alone for 60 min. A2 – Preparation incubated with venom for 60 min. Note that in 
this preparation, there was a slight facilitation after 5 min followed by blockade (the only 
preparation of six in which this was observed). B. Time course of the changes in EPP 
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amplitude following exposure to venom. All experiments were done at room temperature. In 
panel B, the columns are the mean ± SEM (n = 6). *p < 0.05 compared to t0 (basal) values; 
#p 
< 0.05 compared to corresponding control preparations (Tyrode solution alone). 
 
Fig. 10. Compound action potentials recorded in mouse desheathed sciatic nerve preparations. 
A. Minimal effect of M. l. lemniscatus venom (3, 10 and 30 g/ml) on compound action 
potential (CAP) amplitude. B. Representative recordings showing the unaltered CAP 
amplitude in basal conditions (t0, before venom addition) (B1), after a 30 min incubation with 
venom (B2) and after the addition of tetrodotoxin (TTX, 1 M) at the end of the incubation 
with venom (without venom removal) (B3). TTX was added at the end of the experiments to 
confirm that the connective tissue sheath had been removed and sodium channels were 
responsive.  All experiments were done at room temperature. S – stimulus artefact, t30 – end 
of the 30 min incubation with venom. In panel A, the points are the mean ± SEM (n = 5). The 
traces in B1–B3 are representative recordings of the experiments summarized in panel A. 
There were no significant changes in the amplitude, rise time and latency of the potentials 
(see Table 3). 
 
Fig. 11. Neutralization by coral snake antivenom of the neuromuscular blockade caused by 
(A) M. l. lemniscatus and (B) M. frontalis venom in PND preparations. The preparations were 
obtained and mounted as described in section 2.4.2 and allowed to stabilize for 15 min prior 
to the addition of venom or venom preincubated (30 min, 37 oC) with antivenom. Control 
preparations were incubated with Tyrode solution alone. The antivenom used was raised in 
horses against a pool of venoms from M. corallinus and M. frontalis, with 1 ml neutralizing 
1.5 mg of M. frontalis venom (according to the manufacturer; Instituto Butantan). The 
venoms were preincubated with varying antivenom:venom ratios prior to testing, starting with 
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the manufacturer´s recommended ratio and then increasing the amount of antivenom three 
(3:1.5) and ten (10:1.5) times. Note that the neuromuscular blockade caused by M. frontalis 
venom was effectively neutralized by the manufacturer´s recommended antivenom:venom 
ratio whereas similar neutralization of the blockade by M. l. lemniscatus required a 10 times 
higher amount of antivenom. The points are the mean ± SEM (n = 4). *p < 0.05 compared to 
venom alone.  
 
Fig. 12. Reversal by coral snake antivenom of the neuromuscular blockade caused by M. l. 
lemniscatus and M. frontalis venoms after 50% and 80% blockade by each venom in mouse 
PND preparations. Three consecutive additions of antivenom added to the organ baths at the 
manufacturer´s recommended antivenom:venom ratio of 1:1.5 (1 ml of antivenom neutralizes 
1.5 mg of M. frontalis reference venom) were screened for their ability to reverse venom-
induced neuromuscular blockade. The extent of reversal for each addition of antivenom was 
calculated in relation to the corresponding initial degree of blockade. The columns represent 
the mean ± SEM (n = 4). *p < 0.05 compared to the corresponding first addition, p < 0.05 
compared to the corresponding second addition, #, p < 0.05 compared to the first addition for 
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